Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CLN-978 |
Trade Name | |
Synonyms | CLN 978|CLN978 |
Drug Descriptions |
CLN-978 is a bispecific antibody that targets CD19 and CD3, potentially resulting in increased antitumor immune activity (Cancer Res (2022) 82 (12_Supplement): 2077). |
DrugClasses | CD19 Antibody 21 CD3 Antibody 99 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CLN-978 | CLN-978 | 0 | 1 |